Percutaneous drug absorption and administration.
作者信息
Choonara I
机构信息
Institute of Child Health, Alder Hey Children's Hospital, Liverpool.
出版信息
Arch Dis Child Fetal Neonatal Ed. 1994 Sep;71(2):F73-4. doi: 10.1136/fn.71.2.f73.
Abstract
摘要
相似文献
1
Percutaneous drug absorption and administration.经皮给药与药物吸收
Arch Dis Child Fetal Neonatal Ed. 1994 Sep;71(2):F73-4. doi: 10.1136/fn.71.2.f73.
2
Cutaneous pharmacokinetics: 10 steps to percutaneous absorption.皮肤药代动力学：经皮吸收的十个步骤
Drug Metab Rev. 1983;14(2):169-205. doi: 10.3109/03602538308991388.
3
Modern methods of promoting drug absorption through the skin.
Mol Aspects Med. 1991;12(3):195-241. doi: 10.1016/0098-2997(91)90002-4.
4
[The skin and transdermal applications].[皮肤与透皮应用]
Rev Med Liege. 1997 Sep;52(9):585-8.
5
In vitro methods for screening transdermal formulations.透皮制剂的体外筛选方法。
Ther Deliv. 2015;6(9):1043-52. doi: 10.4155/tde.15.58. Epub 2015 Sep 30.
6
Enhanced absorption through damaged skin: an overview of the in vitro human model.经皮破损增强吸收：体外人体模型概述。
Skin Pharmacol Physiol. 2010;23(4):171-6. doi: 10.1159/000288163. Epub 2010 Feb 25.
7
8
Vesicles as tools for the modulation of skin permeability.囊泡作为调节皮肤渗透性的工具。
Expert Opin Drug Deliv. 2007 Nov;4(6):579-93. doi: 10.1517/17425247.4.6.579.
9
The contributions of the Celtic masters and their associates.凯尔特大师及其助手的贡献。
Skin Pharmacol Physiol. 2013;26(4-6):343-55. doi: 10.1159/000352012. Epub 2013 Jul 29.
10
Measurement of bioavailability: measurement of absorption through skin in vitro.生物利用度的测定：体外经皮吸收的测定。
Curr Protoc Toxicol. 2001 May;Chapter 5:Unit 5.1.1-14. doi: 10.1002/0471140856.tx0501s00.
引用本文的文献
1
Meeting Challenges of Pediatric Drug Delivery: The Potential of Orally Fast Disintegrating Tablets for Infants and Children.应对儿科给药挑战：口腔速崩片对婴幼儿的潜力
Pharmaceutics. 2023 Mar 23;15(4):1033. doi: 10.3390/pharmaceutics15041033.
2
Construction of a Nano-Controlled Release Methotrexate Delivery System for the Treatment of Rheumatoid Arthritis by Local Percutaneous Administration.用于局部经皮给药治疗类风湿性关节炎的纳米控释甲氨蝶呤递送系统的构建
Nanomaterials (Basel). 2021 Oct 23;11(11):2812. doi: 10.3390/nano11112812.
3
Learning Lessons from Adverse Drug Reactions in Children.从儿童药物不良反应中吸取教训
Children (Basel). 2016 Jan 8;3(1):1. doi: 10.3390/children3010001.
4
Challenges Associated with Route of Administration in Neonatal Drug Delivery.新生儿给药途径相关的挑战。
Clin Pharmacokinet. 2016 Feb;55(2):185-96. doi: 10.1007/s40262-015-0313-z.
5
Formulations for children: problems and solutions.儿童用药配方：问题与解决方案。
Br J Clin Pharmacol. 2015 Mar;79(3):405-18. doi: 10.1111/bcp.12268.
6
Iodine-induced hypothyroidism in full-term infants with congenital heart disease: more common than currently appreciated?先天性心脏病足月婴儿碘诱发的甲状腺功能减退症：是否比目前认为的更常见？
J Clin Endocrinol Metab. 2014 Oct;99(10):3521-6. doi: 10.1210/jc.2014-1956. Epub 2014 Jul 8.
7
Acetaldehyde involvement in ethanol's postabsortive effects during early ontogeny.乙醛在个体发育早期乙醇吸收后效应中的作用。
Front Behav Neurosci. 2013 Jun 19;7:70. doi: 10.3389/fnbeh.2013.00070. eCollection 2013.
8
Neonatal pharmacology: extensive interindividual variability despite limited size.新生儿药理学：尽管新生儿体型小，但个体间差异很大。
J Pediatr Pharmacol Ther. 2011 Jul;16(3):170-84. doi: 10.5863/1551-6776-16.3.170.
9
Assessing appetitive, aversive, and negative ethanol-mediated reinforcement through an immature rat model.通过未成熟大鼠模型评估乙醇介导的食欲性、厌恶性和负性强化作用。
Neurosci Biobehav Rev. 2009 Jun;33(6):953-74. doi: 10.1016/j.neubiorev.2009.03.008. Epub 2009 Mar 24.
10
The International society for developmental psychobiology 39th annual meeting symposium: Alcohol and development: beyond fetal alcohol syndrome.国际发展心理生物学学会第39届年会专题研讨会：酒精与发育：超越胎儿酒精综合征
Dev Psychobiol. 2007 Apr;49(3):227-42. doi: 10.1002/dev.20224.
本文引用的文献
1
Biotransformation of caffeine in human liver microsomes from foetuses, neonates, infants and adults.咖啡因在胎儿、新生儿、婴儿和成人的人肝微粒体中的生物转化。
Br J Clin Pharmacol. 1994 May;37(5):405-12. doi: 10.1111/j.1365-2125.1994.tb05706.x.
2
Percutaneous lignocaine absorption in newborn infants.新生儿经皮利多卡因吸收情况
Arch Dis Child Fetal Neonatal Ed. 1994 Sep;71(2):F122-4. doi: 10.1136/fn.71.2.f122.
3
Barrier properties of the newborn infant's skin.新生儿皮肤的屏障特性。
J Pediatr. 1983 Mar;102(3):419-25. doi: 10.1016/s0022-3476(83)80669-6.
4
Transdermal drug administration--a nuisance becomes an opportunity.经皮给药——麻烦变成了机遇。
Br Med J (Clin Res Ed). 1981 Oct 3;283(6296):875-6. doi: 10.1136/bmj.283.6296.875.
5
Vehicle effects in percutaneous absorption.载体对经皮吸收的影响。
Drug Metab Rev. 1983;14(2):207-22. doi: 10.3109/03602538308991389.
6
Cutaneous pharmacokinetics: 10 steps to percutaneous absorption.皮肤药代动力学：经皮吸收的十个步骤
Drug Metab Rev. 1983;14(2):169-205. doi: 10.3109/03602538308991388.
7
Outbreak of accidental hexachlorophene poisoning in France.
Lancet. 1982 Jan 9;1(8263):91-5. doi: 10.1016/s0140-6736(82)90225-2.
8
Hexachlorophene myelinopathy in premature infants.
J Pediatr. 1973 Jun;82(6):976-81. doi: 10.1016/s0022-3476(73)80428-7.
9
Dermal absorption of hexochlorophane in infants.婴儿对六氯酚的皮肤吸收
Lancet. 1971 Aug 7;2(7719):296-7. doi: 10.1016/s0140-6736(71)91337-7.
10
Percutaneous administration of theophylline in the preterm infant.
J Pediatr. 1985 Aug;107(2):307-11. doi: 10.1016/s0022-3476(85)80157-8.
Zotero 插件